Client Cephalon (Frazer, PA)
PR agency Vox Medica (Philadelphia)
Campaign "When good medicines become bad drugs" expanded
Duration June-ongoing
Budget Between $200,000-$300,000
As a biopharmaceutical company, Cephalon markets opioid medications, such as Actiq and Fentora, which are generally prescribed for pain.
Though it launched its CSR initiative, "When good medicines become bad drugs," as a webcast in 2008, Cephalon saw a need to build out the effort and target pharmacists, who are vital ...